product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Recombinant Mouse Fibroblast Growth Factor-8, 194 a.a.
catalog :
MBS140958
quantity :
0.005 mg
price :
140 USD
more info or order :
product information
catalog number :
MBS140958
products type :
Recombinant Protein
products full name :
Recombinant Mouse Fibroblast Growth Factor-8, 194 a.a.
products short name :
[Fibroblast Growth Factor-8]
products name syn :
[FGF 8 Mouse, 194 a.a.; Fibroblast Growth Factor-8 Mouse Recombinant, 194 a.a.; FGF8B; FGF-8B; FGF8-B; KAL6; HBGF-8; HBGF8; AIGF; HBGF-8; MGC149376; fibroblast growth factor 8]
other names :
[fibroblast growth factor 8 isoform 3; Fibroblast growth factor 8; fibroblast growth factor 8; fibroblast growth factor 8; Androgen-induced growth factor; AIGF; Heparin-binding growth factor 8; HBGF-8]
products gene name :
[FGF8]
products gene name syn :
[mFGF8]
other gene names :
[Fgf8; Fgf8; Aigf; Fgf-8; Aigf; FGF-8; AIGF; HBGF-8]
uniprot entry name :
FGF8_MOUSE
sequence length :
215
sequence :
MQVTVQSSPN FTQHVREQSL VTDQLSRRLI RTYQLYSRTS GKHVQVLANK RINAMAEDGDPFAKLIVETD TFGSRVRVRG AETGLYICMN KKGKLIAKSN GKGKDCVFTE IVLENNYTAL QNAKYEGWYM AFTRKGRPRK GSKTRQHQRE VHFMKRLPRG HHTTEQSLRF EFLNYPPFTR SLRGSQRTWA PEPR
purity :
Greater than 97.0% as determined by analysis by SDS-PAGE.
form :
Lyophilized from a concentrated (1mg/ml) solution containing 5mM Na3PO4 and 50 mM NaCl, pH 7.5. Sterile Filtered White lyophilized (freeze-dried) powder.
storage stability :
Lyophilized FGF 8 although stable at room temperature for 3 weeks, should be stored desiccated below -18?C. Upon reconstitution FGF 8 should be stored at 4?C between 2-7 days and for future use below -18?C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
other info1 :
Source: Escherichia Coli. Biological Activity: The ED 50 , as determined by its ability to induce proliferation of mouse 3T3 fibroblasts, is 5-7ng/ml, corresponding to a specific activity of 2 x 10 5 units/mg
other info2 :
Solubility: It is recommended to reconstitute the lyophilized FGF 8 in sterile 18M-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.
products categories :
CYTOKINES AND GROWTH FACTORS
products description :
Introduction: FGF8 is part of the fibroblast growth factor family. FGF family members have wide mitogenic and cell survival activities, and participate in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF8 supports androgen and anchorage independent growth of mammary tumor cells. FGF8 over expression increases tumor growth and angiogensis. The adult expression of FGF-8 gene is restricted to testes and ovaries. FGF8 functions as an embryonic epithelial factor. FGF8 takes part in midbrain and limb development, organogenesis, embryo gastrulation and left-right axis determination. Description: FGF 8 Mouse Recombinant produced in E Coli is a non-glycosylated polypeptide chain containing 194 amino acids and having a total molecular mass of 22.5kDa.
ncbi gi num :
261599076
ncbi acc num :
NP_001159834.1
ncbi gb acc num :
NM_001166362.1
uniprot acc num :
P37237
ncbi mol weight :
23,522 Da
ncbi pathways :
ARMS-mediated Activation Pathway (1324638); Adaptive Immune System Pathway (1323640); Axon Guidance Pathway (1323598); Cytokine Signaling In Immune System Pathway (1323763); DAP12 Interactions Pathway (1323743); DAP12 Signaling Pathway (1323744); Developmental Biology Pathway (1323597); Dopminergic Neurogenesis Pathway (198342); Downstream Signal Transduction Pathway (1324645); Downstream Signaling Events Of B Cell Receptor (BCR) Pathway (1323654)
uniprot summary :
FGF8: Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. Required for normal brain, eye, ear and limb development during embryogenesis. Required for normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Defects in FGF8 are the cause of Kallmann syndrome type 6 (KAL6). Kallmann syndrome is a disorder that associates hypogonadotropic hypogonadism and anosmia. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone- synthesizing neurons. In some patients other developmental anomalies can be present, which include renal agenesis, cleft lip and/or palate, selective tooth agenesis, and bimanual synkinesis. In some cases anosmia may be absent or inconspicuous. Defects in FGF8 are a cause of idiopathic hypogonadotropic hypogonadism (IHH). IHH is defined as a deficiency of the pituitary secretion of follicle-stimulating hormone and luteinizing hormone, which results in the impairment of pubertal maturation and of reproductive function. Belongs to the heparin-binding growth factors family. 4 isoforms of the human protein are produced by alternative splicing. Protein type: Cytokine; Secreted; Secreted, signal peptide. Cellular Component: external side of plasma membrane. Molecular Function: chemoattractant activity. Biological Process: adrenocorticotropin hormone secreting cell differentiation; apoptosis; blood vessel remodeling; BMP signaling pathway; cell fate commitment; cell proliferation in forebrain; central nervous system neuron development; determination of left/right symmetry; dorsal/ventral axon guidance; embryonic development ending in birth or egg hatching; embryonic heart tube development; embryonic hindlimb morphogenesis; fibroblast growth factor receptor signaling pathway; forebrain dorsal/ventral pattern formation; forebrain morphogenesis; forebrain neuron development; generation of neurons; gonad development; heart development; heart looping; heart morphogenesis; induction of an organ; inner ear morphogenesis; kidney development; limb morphogenesis; lung development; male genitalia development; MAPKKK cascade; mesodermal cell migration; midbrain-hindbrain boundary development; motor axon guidance; negative regulation of apoptosis; negative regulation of cardiac muscle development; negative regulation of neuron apoptosis; neural plate morphogenesis; otic vesicle formation; pallium development; patterning of blood vessels; pharyngeal system development; positive regulation of cell proliferation; positive regulation of mitosis; positive regulation of organ growth; regulation of odontogenesis of dentine-containing teeth; response to oxidative stress; subpallium development; telencephalon development; thyroid gland development; thyroid stimulating hormone secreting cell differentiation; ureteric bud branching; Wnt receptor signaling pathway through beta-catenin
size1 :
0.005 mg
price1 :
140 USD
size2 :
0.025 mg
price2 :
205
size3 :
1 mg
price3 :
2665
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!